• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: patient

  • Routine Angioplasty Recommended After Thrombolysis
    • in Cardiovascular
    • — 6 Apr, 2008

    Routine Angioplasty Recommended After Thrombolysis

    Warren Cantor
    Warren Cantor
    Tony Gershlick
    Tony Gershlick

    REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction
    Warren Cantor, University of Toronto
    COMMENT: Tony Gershlick, Leicester University

    A new study has shown important gains from adding angioplasty routinely to therapy for all
    …
    Read more
    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer
    • in General Medicine
    • — 21 Mar, 2008

    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

    Giorgio Scagliotti
    Giorgio Scagliotti
    Robert Pirker
    Robert Pirker

    GIORGIO SCAGLIOTTI, University of Turin
    ROBERT PIRKER, Medical University of Vienna
    A heated debate took place at the European Congress on Lung Cancer in Turin between Robert Pirker who is in favor of offering
    …
    Read more
  • Front Line Therapy in Non-Small Cell Lung Cancer
    • in Oncology
    • — 17 Mar, 2008

    Front Line Therapy in Non-Small Cell Lung Cancer

    Nick Thatcher
    Nick Thatcher

    NICK THATCHER, Christie Hospital, Manchester
    There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his
    …
    Read more
    Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
    • in Oncology
    • — 16 Mar, 2008

    Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

    Christian Manegold
    Christian Manegold
    Nick Thatcher
    Nick Thatcher
    Christian Manegold, Heidelberg University Medical Center, Manheim
    Nick Thatcher, Christie Hospital, Manchester

    Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question

    …
    Read more
  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
    • in News
    • — 16 Mar, 2008

    Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

    Robert Pirker
    Robert Pirker

    ROBERT PIRKER , Medical University of Vienna
    Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.
    …
    Read more
    “Total Therapy” Possible Cure For Multiple Myeloma?
    • in Oncology
    • — 26 Feb, 2008

    “Total Therapy” Possible Cure For Multiple Myeloma?

    Bart Barlogie
    Bart Barlogie

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    BART BARLOGIE, University of Arkansas, Little Rock
    A treatment known as “total therapy” could cure many patients with multiple myeloma, conference-goers have just heard. The targeted
    …
    Read more
  • London School of Hygiene & Tropical Medicine Audio News – Europe’s Surge Against Cancer
    • in Public Health
    • — 7 Feb, 2008

    London School of Hygiene & Tropical Medicine Audio News – Europe’s Surge Against Cancer

    Michel Coleman
    Michel Coleman

    Michel Coleman (London School of Hygiene and Tropical Medicine) explains how cancer will become a new priority in the EU.

    …
    Read more
    Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
    • in Oncology
    • — 1 Feb, 2008

    Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

    Cora Sternberg
    Cora Sternberg
    REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    CORA STERNBERG, San Camillo and Forlanini Hospital, Rome
    Satraplatin could provide a new option for patients with hormone refractory prostate cancer, by giving
    …
    Read more
  • Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer
    • in Oncology
    • — 27 Jan, 2008

    Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer

    Charles Hsu
    Charles Hsu

    CHARLES HSU, Johns Hopkins University, Baltimore
    Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin
    …
    Read more
    Meta-Analysis Proves Statins Help Patients With Diabetes
    • in General Medicine
    • — 11 Jan, 2008

    Meta-Analysis Proves Statins Help Patients With Diabetes

    Colin Baigent
    Colin Baigent

    REFERENCE: Lancet 371:117 January 11, 2008
    COLIN BAIGENT, Oxford University
    Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in a meta-analysis of 18 000
    …
    Read more
  • Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
    • in General Medicine
    • — 4 Jan, 2008

    Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

    Peter Tyrer
    Peter Tyrer

    REFERENCE: Lancet 371:57 January 5, 2008
    PETER TYRER, Imperial College, W6 8RP London
    A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Ibritumomab Provides Benefit in Patients with Follicular Lymphoma

    Anton Hagenbeek
    Anton Hagenbeek

    ANTON HAGENBEEK, University Medical Centre Utrecht
    For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: patient

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.